Half-year report · Q2
177A.TEDINET S100UQDH
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 29
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥4.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Operating income | ¥380m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥417m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥636m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥367m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥277m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥385m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥277m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥8.5bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥6.6bn | at 2024-03-31 | Cons. | Assets |
| Total liabilities | ¥3.2bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥3.2bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.3bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2024-03-31 | Cons. | Net assets |
| Cash and deposits | ¥3.3bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.3bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥518m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥824m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥467m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥577m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥55.7 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥92.43 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 62.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 13
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥265m |
| jpcrp040300-q2r_E38689-000Cell Process Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥630m |
| jpcrp040300-q2r_E38689-000Cell Process Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥630m |
| jpcrp040300-q2r_E38689-000Cell Process Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥191m |
| jpcrp040300-q2r_E38689-000Microbiological Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥777m |
| jpcrp040300-q2r_E38689-000Microbiological Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥777m |
| jpcrp040300-q2r_E38689-000Microbiological Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥104m |
| jpcrp040300-q2r_E38689-000Tissue Culture Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E38689-000Tissue Culture Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E38689-000Tissue Culture Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥350m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥2.5bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥2.5bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥645m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 351
| Item | Context | Value | Unit |
|---|---|---|---|
| Selling general and administrative expenses | CurrentYTDDuration | 679280000 | JPY |
| Operating income | CurrentYTDDuration | 379782000 | JPY |
| Interest income noi | CurrentYTDDuration | 524000 | JPY |
| Dividends income noi | CurrentYTDDuration | 84000 | JPY |
| Rent income noi | CurrentYTDDuration | 5618000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | 55988000 | JPY |
| Other noi | CurrentYTDDuration | 3636000 | JPY |
| Non operating income | CurrentYTDDuration | 65851000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 14325000 | JPY |
| Commission fee noe | CurrentYTDDuration | 10070000 | JPY |
| Other noe | CurrentYTDDuration | 4358000 | JPY |
| Non operating expenses | CurrentYTDDuration | 28754000 | JPY |
| Ordinary income | CurrentYTDDuration | 416879000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 1608000 | JPY |
| Extraordinary income | CurrentYTDDuration | 1608000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 520000 | JPY |
| Loss due to core system change el | CurrentYTDDuration | 51172000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 51693000 | JPY |
| Income before income taxes | CurrentYTDDuration | 366794000 | JPY |
| Income taxes | CurrentYTDDuration | 89597000 | JPY |
| Profit loss | CurrentYTDDuration | 277196000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 277196000 | JPY |
| Profit loss | CurrentYTDDuration | 277196000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 383000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 63106000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 63490000 | JPY |
| Comprehensive income | CurrentYTDDuration | 340686000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 340686000 | JPY |
| Income before income taxes | CurrentYTDDuration | 366794000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 175584000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -24714000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | 15678000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 1026000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -609000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 14325000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | -55988000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYTDDuration | -1608000 | JPY |
| Loss on retirement of noncurrent assets ope cf | CurrentYTDDuration | 520000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 74786000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | 8954000 | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYTDDuration | 3285000 | JPY |
| Decrease increase in consumption taxes refund receivable ope cf | CurrentYTDDuration | 2134000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -22961000 | JPY |
| Increase decrease in accounts payable other and accrued expenses ope cf | CurrentYTDDuration | -23218000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | 2672000 | JPY |
| Other net ope cf | CurrentYTDDuration | 35928000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 572592000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 542000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -14607000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -40382000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |